This year saw outstanding results from the hospital operators, in particular, Ramsay Healthcare (RHC). Results were at the top end of consensus forecasts, and expectations are for continued robust growth. Over the last 20 year, RHC has produced an average of 16% compound earnings growth, and this looks like it will continue; we maintain our add rating. However, it's worth noting that Healthscope is trading at a lower multiple, and its growth profile looks more attractive. We also have an add recommendation on Healthscope as the growth profile should increase share price performance. In the video below, Morgans Senior Analyst, Scott Power, provides an update on the aged care sector, the IVF operators, Impedimed, and Nanosonics.
Morgans is Australia's largest national full-service retail stockbroking and wealth management firm, with more than 300,000 clients, 500 authorised representatives and 850 staff, operating from offices in all states and territories. As well as...
No areas of expertise